Transverse myelitis describes a neurological syndrome characterized by inflammation within the spinal cord, typically spanning multiple contiguous segments and disrupting both sensory and motor pathways. This condition manifests with rapid onset of bilateral weakness, sensory disturbances, and autonomic dysfunction, representing a critical neurological emergency. Understanding the intricate pathophysiology of transverse myelitis is essential for accurate diagnosis, effective management, and the development of targeted therapeutic strategies.
Defining the Anatomical and Functional Framework
The spinal cord serves as the primary conduit for ascending sensory information and descending motor commands, organized into distinct tracts that facilitate specific functions. Inflammation in transverse myelitis preferentially affects the gray matter, including the anterior horn cells, and the surrounding white matter tracts, leading to segmental dysfunction. This anatomical involvement explains the classic presentation of a "transverse" sensory level, where sensation is lost below a specific dermatome, alongside bilateral motor deficits and bowel or bladder impairment.
Inflammatory Mechanisms and Immune Mediation
The core pathophysiological process involves an autoimmune-mediated attack on the central nervous system (CNS) myelin and axonal structures. This inflammation can be triggered by various factors, including systemic infections or autoimmune disorders, which may initiate a misdirected immune response. Key immune cells, such as activated T lymphocytes and macrophages, infiltrate the spinal cord parenchyma, releasing pro-inflammatory cytokines and reactive oxygen species that directly damage the myelin sheath and underlying axons.
Role of Demyelination and Axonal Injury
Demyelination is a primary event that disrupts the normal saltatory conduction of electrical impulses along nerve fibers, resulting in slowed or blocked signal transmission. While demyelination is a central feature, contemporary evidence strongly suggests that significant axonal injury occurs early in the disease course. This axonal damage, potentially driven by excitotoxicity and mitochondrial dysfunction, is a major determinant of permanent neurological deficits and disability, highlighting the importance of neuroprotective strategies.
Classification and Associated Etiologies
Transverse myelitis is clinically categorized based on its association with underlying conditions, which provides crucial insights into its pathophysiology. Idiopathic transverse myelitis, where no specific cause is identified, is often considered a syndrome that may align with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD). Secondary forms are linked to systemic autoimmune diseases like lupus, infections such as varicella-zoster virus, or paraneoplastic syndromes, each triggering distinct inflammatory cascades within the spinal cord.
Clinical and Diagnostic Correlates
Diagnosis relies heavily on a combination of clinical assessment and magnetic resonance imaging (MRI) findings. MRI typically reveals T2 hyperintensity within the affected spinal cord segments, often with contrast enhancement indicating active inflammation. Cerebrospinal fluid analysis may show pleocytosis and elevated immunoglobulin G synthesis, while evoked potential studies can subclinically detect demyelination. These investigations are critical not only for confirming the diagnosis but also for excluding alternative etiologies such as structural lesions or vascular insults.
